Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) (“Jack Nathan Health”, “JNH” or the “Company”) is pleased to announce that its Mexican subsidiary, Jack Nathan Health Mexico, started operations of its first medical center in Mexico city, Mexico. This state-of-the-art facility will provide a wide range of comprehensive healthcare services, including: general medicine, internal medicine, pediatrics, laboratory services, nutrition counseling, psychology, ul

OM1, a leading real-world data, AI, and technology company with a focus on chronic diseases, announced the launch of two new clinical datasets, Chronic Rhinosinusitis (CRS) and Asthma. Both datasets are derived from longitudinal follow-up of patients seen by specialists and focus on patient characteristics, symptoms, treatments, clinical outcomes and healthcare resource utilization. Rapidly growing, the CRS and Asthma datasets each follow approximately 500,000 patients in the U

Sengenics Corporation LLC, a leader in immune response profiling to support scientific discovery and diagnostic development, today announced the launch of i-Ome Discovery, a comprehensive protein microarray platform for the analysis of autoantibodies associated with disease diagnosis and therapeutic intervention. The i-Ome Discovery platform was developed to support academic and clinical biopharmaceutical research teams who are seeking to better understand the dynamic interactions and relatio

Modern Healthcare has named IVX Health as one of the Best Places to Work in Healthcare in 2023, an annual program that identifies and honors 150 outstanding companies and organizations in the healthcare industry nationwide. Modern Healthcare ranked IVX Health No. 45 overall in one of its two category designations. This award marks the fifth consecutive year IVX Health has been recognized in the prestigious Best Places to Work list. "An uncertain economy, staffing shor

AccuLine, a digital health startup company, has announced today a collaboration with Mayo Clinic through a know-how license agreement for the advancement of CORA, AccuLine's novel solution designed for the early detection of coronary artery disease (CAD).  As part of the agreement, Mayo Clinic will become a shareholder in AccuLine. CAD stands as the leading trigger for heart attacks, which are the number one cause of death globally. Given its grave implications, e

Vida Health announced its expansion into Spanish-language medical prescribing services for treating physical and mental health conditions together, solidifying Vida’s position as a leader in comprehensive cardiometabolic virtual care and its commitment to equitable care. Vida’s Spanish-language medical prescribing capabilities will enhance the care interventions Vida providers can use to help Spanish-speaking members with higher-severity conditions see greater healt

Komodo Health today introduced MapLab™, the first all-in-one offering for healthcare and Life Sciences companies to generate insights into disease trends, treatment pathways, patient populations, and a host of other complex research questions. The technology ushers in a new, fully integrated insights workflow solution for the industry to more easily and rapidly unearth rich insights that will help reduce disease burden at scale. MapLab includes robust data science tooling, customizable

Atropos Health, a pioneer in evidence-based healthcare known for its Green Button Clinical Informatics Consult Service, today announced an agreement with Janssen Research & Development, LLC (Janssen), a Johnson & Johnson company, to help accelerate clinical development with real-world data analysis. Building upon an existing collaboration, under the new agreement, Atropos and Janssen data scientists will utilize Atropos’s software platform to interrogate Janssen’

VITAL, a new Hispanic-owned health benefits company that designs affordable health plans for the diverse U.S. Hispanic community, today announced its launch. Poised to operate across the country, VITAL (pronounced Vee-TAHL) was created to support the health and well-being of Hispanic families by removing barriers to care and empowering companies to create and maintain their own low-cost health care plans. The company launch event took place in Washington, D.C. near Ca

Saluda Medical, Inc. ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies, today announced that the U.S. Food and Drug Administration (FDA) has approved MRI conditional labeling for the Evoke® System, the first and only precision, dose-control spinal cord stimulation (SCS) therapy powered by SmartLoop™ technology. This approval app